| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.20▲ | 7.20▲ | 7.20▲ | 7.25▲ | 6.94▲ |
| MA10 | 7.03▲ | 7.08▲ | 7.12▲ | 7.16▲ | 6.99▲ |
| MA20 | 7.05▲ | 7.08▲ | 7.06▲ | 7.13▲ | 7.15▲ |
| MA50 | 6.90▲ | 6.99▲ | 6.96▲ | 7.05▲ | 6.36▲ |
| MA100 | 6.96▲ | 6.87▲ | 6.90▲ | 7.10▲ | N/A |
| MA200 | 7.30▲ | 7.69▼ | 7.77▼ | 6.51▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.039▲ | 0.036▲ | 0.037▲ | 0.009▲ | N/A |
| RSI | 58.097▲ | 57.233▲ | 57.049▲ | 53.082▲ | N/A |
| STOCH | 71.565 | 69.763 | 67.748 | 47.594 | 32.770 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -36.283 | -50.000 |
| CCI | 101.816▲ | 89.351 | 92.758 | 18.317 | 58.056 |
| BBANDS | $ARDS Bollinger Bands Expanding | Set Alert |
|
Tuesday, September 08, 2020 03:54 AM
Aridis Pharmaceuticals (NASDAQ:ARDS) has reached an agreement with the FDA to simplify its AR-501 Phase 2 trial design for the treatment of chronic lung infections associated with cystic fibrosis ...
|
|
Tuesday, September 08, 2020 02:41 AM
SAN JOSE, Calif., Sept. 8, 2020 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies ...
|
|
Tuesday, September 08, 2020 02:30 AM
PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/09/20 | 7.00 | 7.50 | 6.86 | 7.34 | 31,696 |
| 17/09/20 | 7.06 | 7.255 | 6.87 | 7.11 | 26,022 |
| 16/09/20 | 7.27 | 7.39 | 7.12 | 7.39 | 14,100 |
| 15/09/20 | 7.3611 | 7.3611 | 6.93 | 7.28 | 6,733 |
| 14/09/20 | 6.73 | 7.13 | 6.73 | 7.13 | 7,106 |
| 11/09/20 | 6.92 | 7.00 | 6.73 | 6.73 | 3,249 |
| 10/09/20 | 7.1053 | 7.1053 | 6.8001 | 6.885 | 5,978 |
| 09/09/20 | 7.34 | 7.74 | 7.11 | 7.11 | 2,488 |
| 08/09/20 | 7.21 | 7.73 | 7.05 | 7.70 | 14,500 |
| 04/09/20 | 7.2501 | 7.74 | 6.62 | 6.94 | 8,049 |
|
|
||||
|
|
||||
|
|